Close Menu

NEW YORK – Boston-based NanoView Biosciences has signed an exclusive agreement with Isaza Scientific to distribute Nanoview's ExoView platform in Spain and Portugal.

The research-use-only ExoView platform is an antibody labeling and imaging-based extracellular vesicle detection tool that provides high-resolution sizing, counting, and phenotyping. NanoView said that the platform requires minimal sample input, no sample prep or purification, and can be used directly with complex biological samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.